The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.
08 April 2014
Experts from the three UK HTA agencies, the MHRA, and academia discussed which HTA methods are most appropriate for biosimilars in specific situations.
31 March 2014
This publication reviews the limited use of cost-effectiveness evidence in the US and explores the potential value of expanding its use, particularly in Medicare.
18 March 2014
The OHE model takes into account the value to society of new antibiotics as well as the risks and rewards for payers and the entities developing the new drugs.
11 March 2014
Under an MRC grant, OHE is collaborating to estimate in monetary terms the synergies of medical research spending in the UK by the pharma industry, charities and the public sector.
04 March 2014
A new publication reports that GPs were motivated to improve performance and that low-performing GPs improved the most.